Nearly two years ago now, Stryker Corporation, major manufacturer of medical devices including hip implant systems, circulated a release concerning "higher than expected complaints" of failures with the lock on one of their more popular products. According to Stryker itself, certain batches of its Stryker LFIT Anatomic CoCr V40TM femoral heads manufactured prior to 2011 involved an increased risk of metallosis and hip dislocation as a result of "taper lock failure." What followed was a recall of approximately 42,000 of the Stryker hip implant systems.
Stryker Updates Its Product Safety Notice on Hip Implant System
Following its warning two years ago, Stryker recently updated the public about the LFIT Anatomic CoCr V40TM product line, and the news is not good. Stryker again warned orthopedic surgeons implanting the femoral heads that the risk continues to be "higher than expected" and in addition the company added eight more catalog numbers to its official recall list. The total list now stands at 15 items. Below are the new additions:
Potential Dangers of LFIT V40 Femoral Heads
In addition to the reiteration of the early warning and the supplemental list of catalog numbers, Stryker also offered a daunting list of potential complications which may arise from the use of its femoral head implants. This list was intended for orthopedic surgeons to consider before undertaking a procedure involving the implant system, but every patient should also be aware of the significant risks posed by this technology. Below is the list of potential clinical complications:
- Pain associated with implant loosening
- Peri-prosthetic fracture
- Revision to alleviate hazardous situation
- Leg length discrepancy
- Loss of mobility secondary to hip/stem trunnion fracture or femoral head/hip stem dissociation
- Pain requiring revision surgery
- Inflammatory response
- Adverse local tissue reaction (ALTR)
Stryker Hip Implant Settlements Reach $1 Billion
In the past few years, Stryker has faced thousands of lawsuits related to its hip replacement systems, including the LFIT V40 but also Rejuvenate and ABG II. The company recalled the latter two devices in 2012, which lead to waves of lawsuits, eventually resulting in settlements of more than $1 Billion.
Now, Stryker faces a new wave of litigation over allegations that those implanted with the LFIT V40 experienced serious injuries. For the purposes of streamlining the legal process, all federally-filed lawsuits over the LFIT were centralized in the US District Court for the District of Massachusetts. The first bellwether trial for this Mass District Litigation is scheduled to occur in September 2019.
Individuals who have received the LFIT V40 and who believe that they have suffered or may suffer injuries as a result of the femoral head implant should consider their legal options accordingly.